Royal Bank of Canada
MDCO

Royal Bank of Canada’s Medicines Co MDCO Stock Holding History

Royal Bank of Canada’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-300
Closed -$11K – 7400
2019
Q2 		$11K Buy
+300
New +$9.79K ﹤0.01% 6009
2015
Q4 		– Sell
-30,100
Closed -$1.14M – 6954
2015
Q3 		$1.14M Buy
+30,100
New +$1.06M ﹤0.01% 2744

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Royal Bank of Canada's MDCO Position: Q1 2020 in Review

Royal Bank of Canada sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 178,062 shares — an estimated $15.1M sold.

Royal Bank of Canada first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $15.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Royal Bank of Canada reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 178,062 Medicines Co shares in Q1 2020, an estimated $15.1M.
  • Royal Bank of Canada first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
  • Royal Bank of Canada's Medicines Co position peaked at $15.1M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Royal Bank of Canada's 13F filing for Q1 2020, filed 15 May 2020.